Switching from clopidogrel to prasugrel resolves vascular inflammation in patients receiving long-term aspirin plus clopidogrel therapy after coronary stent implantation

J Nucl Cardiol. 2021 Jun;28(3):1191-1192. doi: 10.1007/s12350-020-02110-7. Epub 2020 Mar 31.

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
² Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. ntahara@med.kurume-u.ac.jp.
³ Daiichi Sankyo Co., Ltd., Tokyo, Japan.
⁴ Department of Radiology, Kurume University School of Medicine, Kurume, Japan.

PMID: 32236837
DOI: 10.1007/s12350-020-02110-7

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Aspirin / therapeutic use
Clopidogrel / therapeutic use*
Female
Fluorodeoxyglucose F18 / pharmacokinetics
Humans
Male
Percutaneous Coronary Intervention*
Platelet Activation / physiology*
Platelet Aggregation Inhibitors / therapeutic use*
Positron Emission Tomography Computed Tomography
Prasugrel Hydrochloride / therapeutic use*
Radiopharmaceuticals / pharmacokinetics
Stents*

Substances

Platelet Aggregation Inhibitors
Radiopharmaceuticals
Fluorodeoxyglucose F18
Clopidogrel
Prasugrel Hydrochloride
Aspirin